Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses
Heinz Laübli, Ajit Varki
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 4, pp. 593-605
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Global view of human protein glycosylation pathways and functions
Katrine T. Schjoldager, Yoshiki Narimatsu, Hiren J. Joshi, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 12, pp. 729-749
Closed Access | Times Cited: 908
Insights into the role of sialylation in cancer progression and metastasis
Christopher Dobie, Danielle Skropeta
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 76-90
Open Access | Times Cited: 238
Versican—A Critical Extracellular Matrix Regulator of Immunity and Inflammation
Thomas N. Wight, Inkyung Kang, Stephen P. Evanko, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 203
Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
Stephanie van de Wall, Kim Santegoets, Eline J.H. van Houtum, et al.
Trends in Immunology (2020) Vol. 41, Iss. 4, pp. 274-285
Closed Access | Times Cited: 159
Aberrant Sialylation in Cancer: Therapeutic Opportunities
Jennifer Munkley
Cancers (2022) Vol. 14, Iss. 17, pp. 4248-4248
Open Access | Times Cited: 70
Biological function of sialic acid and sialylation in human health and disease
Wengen Zhu, Yue Zhou, Linjuan Guo, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
Natália Rodrigues Mantuano, Marina Natoli, Alfred Zippelius, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001222-e001222
Open Access | Times Cited: 93
Siglec Ligands
Anabel Gonzalez-Gil, Ronald L. Schnaar
Cells (2021) Vol. 10, Iss. 5, pp. 1260-1260
Open Access | Times Cited: 75
Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
Charlotte Castenmiller, Brigitte-Carole Keumatio-Doungtsop, Ronald van Ree, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
Siglec receptors as new immune checkpoints in cancer
Michal A. Stanczak, Heinz Laübli
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101112-101112
Open Access | Times Cited: 61
Targeting the Siglec–Sialic Acid Immune Axis in Cancer: Current and Future Approaches
Heinz Laübli, Sam C. Nalle, Daniel Maslyar
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1423-1432
Open Access | Times Cited: 56
Establishment of fetomaternal tolerance through glycan-mediated B cell suppression
Gabrielle Rizzuto, Jeremy F. Brooks, Sami T. Tuomivaara, et al.
Nature (2022) Vol. 603, Iss. 7901, pp. 497-502
Open Access | Times Cited: 47
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
Hannah Egan, Oliver Treacy, Kevin Lynch, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112475-112475
Open Access | Times Cited: 38
Sialic acid O-acetylation patterns and glycosidic linkage type determination by ion mobility-mass spectrometry
Gaël M. Vos, Kevin C. Hooijschuur, Zeshi Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2
Ronja Wieboldt, Michael T. Sandholzer, Emanuele Carlini, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 5, pp. 495-509
Open Access | Times Cited: 12
The transcriptional landscape of glycosylation-related genes in cancer
Ernesto Rodríguez, Dimitri Lindijer, Sandra J. van Vliet, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109037-109037
Open Access | Times Cited: 9
A nanobody-enzyme fusion protein targeting PD-L1 and sialic acid exerts anti-tumor effects by C-type lectin pathway-mediated tumor associated macrophages repolarizing
Yongliang Tong, Runqiu Chen, Xinrong Lu, et al.
International Journal of Biological Macromolecules (2025), pp. 139953-139953
Closed Access | Times Cited: 1
Targeted Tumor Delivery Using Extracellular Vesicles
Hema Saranya Ilamathi, Samir EL Andaloussi, Oscar P. B. Wiklander
Methods in pharmacology and toxicology (2025), pp. 125-153
Closed Access | Times Cited: 1
Growth factor-triggered de-sialylation controls glycolipid-lectin-driven endocytosis
Ewan MacDonald, Alison Forrester, César Augusto Valades-Cruz, et al.
Nature Cell Biology (2025)
Closed Access | Times Cited: 1
Sialic acid metabolism-based classification reveals novel metabolic subtypes with distinct characteristics of tumor microenvironment and clinical outcomes in gastric cancer
Junjie Jiang, Yiran Chen, Yangyang Zheng, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands
Emily Rodrigues, Jaesoo Jung, Heajin Park, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 69
Glycan Microarrays as Chemical Tools for Identifying Glycan Recognition by Immune Proteins
Chao Gao, Mohui Wei, Tanya R. McKitrick, et al.
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 68
Biomedical nanomaterials for immunological applications: ongoing research and clinical trials
Vincent Lenders, Xanthippi Koutsoumpou, Ara Sargsian, et al.
Nanoscale Advances (2020) Vol. 2, Iss. 11, pp. 5046-5089
Open Access | Times Cited: 64
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
Corleone S. Delaveris, Aaron J. Wilk, Nicholas M. Riley, et al.
ACS Central Science (2021) Vol. 7, Iss. 4, pp. 650-657
Open Access | Times Cited: 55
Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype
Richard Beatson, Rosalind Graham, Fabio Grundland Freile, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top